Literature DB >> 18508726

Role of proteasomes in transcription and their regulation by covalent modifications.

Alexey G Mittenberg1, Tatyana N Moiseeva, Nickolai A Barlev.   

Abstract

The 26S proteasome is an abundant multi-subunit complex, which, in addition to lysosomes, represents a major cellular "protein degradation factory". The proteasome complex possesses protease, ATPase/helicase, and RNAse enzymatic activities, which are used by the latter to regulate various physiological processes. Recent findings have revealed an important role of proteasomes in transcriptional regulation. Although proteasomes are well documented to undergo various post-translational modifications, little is known about their functional significance, in particular in the process of gene regulation in response to various forms of stress. Here, we review the data on the role of proteasomes in gene regulation and their post-translational modifications as well as discuss potential mechanisms by which proteasomal activity may be regulated by genotoxic stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508726     DOI: 10.2741/3220

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  16 in total

Review 1.  Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription.

Authors:  Brian R Keppler; Trevor K Archer; H Karimi Kinyamu
Journal:  Biochim Biophys Acta       Date:  2010-08-20

2.  Regulation of Endoribonuclease Activity of Alpha-Type Proteasome Subunits in Proerythroleukemia K562 Upon Hemin-Induced Differentiation.

Authors:  Alexey G Mittenberg; Tatyana N Moiseeva; Valeria O Kuzyk; Nickolai A Barlev
Journal:  Protein J       Date:  2016-02       Impact factor: 2.371

Review 3.  The role of the proteasome in heart disease.

Authors:  Yi-Fan Li; Xuejun Wang
Journal:  Biochim Biophys Acta       Date:  2010-09-15

4.  Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4.

Authors:  David Gagnon; Simon Joubert; Hélène Sénéchal; Amélie Fradet-Turcotte; Sabrina Torre; Jacques Archambault
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

5.  Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.

Authors:  Alexey G Mittenberg; Valeria O Kuzyk; Sergey V Shabelnikov; Daria P Gorbach; Alla N Shatrova; Olga A Fedorova; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2018-08-01       Impact factor: 4.534

6.  Proteasome subunits relocalize during human cytomegalovirus infection, and proteasome activity is necessary for efficient viral gene transcription.

Authors:  Karen Tran; Jeffrey A Mahr; Deborah H Spector
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

Review 7.  Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems.

Authors:  Ivano Amelio; Vivien Landré; Richard A Knight; Andrey Lisitsa; Gerry Melino; Alexey V Antonov
Journal:  Oncotarget       Date:  2015

8.  miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress.

Authors:  L Lezina; N Purmessur; A V Antonov; T Ivanova; E Karpova; K Krishan; M Ivan; V Aksenova; D Tentler; A V Garabadgiu; G Melino; N A Barlev
Journal:  Cell Death Dis       Date:  2013-12-12       Impact factor: 8.469

9.  DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity.

Authors:  Tatiana N Moiseeva; Andrew Bottrill; Gerry Melino; Nickolai A Barlev
Journal:  Oncotarget       Date:  2013-09

10.  KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress.

Authors:  L Lezina; V Aksenova; T Ivanova; N Purmessur; A V Antonov; D Tentler; O Fedorova; A V Garabadgiu; I Talianidis; G Melino; N A Barlev
Journal:  Cell Death Differ       Date:  2014-08-15       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.